Phase 1b study of TAK-659+nivolumab (nivo) in patients (pts) with advanced solid tumors. Meeting Abstract (Web of Science)

cited authors

  • Juric, Dejan; Olszanski, Anthony J.; Vaishampayan, Ulka N.; Li, Cong; Wang, Shining; Shou, Yaping; Rong, Yuanxin; Nemunaitis, John

publication date

  • May 20, 2018

webpage

published in

category

volume

  • 36

issue

  • 15